Cooper Institute for Reproductive Hormonal Disorders

Recent papers from Cooper Institute for Reproductive Hormonal Disorders

1. Parathyroid Hormone-related Peptide Is a Better Indicator of Cancer Treatment Efficacy Than Serum CalciumAnticancer Research · 2026
2. Marked Palliative Benefits Seen With Treatment of Very Advanced Breast Cancer With the Progesterone Receptor Modulator MifepristoneAnticancer Research · 2026
3. Good Quality 66.7% 5-year Overall Survival in Terminal Lung Cancer Patients Treated With MifepristoneAnticancer Research · 2025
4. New Insight into the Etiology and Treatment of the Vulvostomatodynia and Review of Treating Pelvic Pain with Dopaminergic DrugsGynecology & Reproductive Health · 2024
5. Novel Immunoendocrine Therapy of Advanced Cancers of all types Opens a New Medical Field for Clinical and Research Endocrinologists2024
6. Combined Dopaminergic Drugs with Supplemental Progesterone to Treat Recurrent Miscarriage and Ulcerative Colitis despite Diminished Egg ReserveGynecology & Reproductive Health · 2024
7. Combined Dopaminergic Drugs with Supplemental Progesterone to Treat Recurrent Miscarriage and Ulcerative Colitis despite Diminished Egg ReserveGynecology & Reproductive Health · 2024
8. A Comparison of the Frequency of Trisomy 13, 18, and 21 Using Non-Invasive Prenatal Testing According to Diminished vs. Normal Egg Reserve and AgeReproductive Medicine · 2024
9. Effect of Women’s Age on Pregnancy Outcome with a Triple Line Pattern in Mid Luteal Phase in Frozen-Thawed Embryo Transfer CyclesJournal of Medical - Clinical Research & Reviews · 2024
10. A Novel Effective Therapy for Chronic Generalized Pruritus without Presence of Skin LesionsJournal of Medical - Clinical Research & Reviews · 2024
11. #1697008 Palliative benefits of treatment of advanced urothelial cancer with a progesterone receptor antagonistEndocrine Practice · 2024
12. A Study to Determine the Impact of Diminished Oocyte Reserve (DOR) on Pregnancy Outcome in Women of Advanced Reproductive AgeGynecology & Reproductive Health · 2024
13. A Novel Treatment of Crohn’s Disease that is Not Only Safe in Pregnancy but Can Correct Infertility and Recurrent MiscarriagesGynecology & Reproductive Health · 2024
14. High Anti-Mullerian Hormone (AMH) Levels Do Not Impact Live Delivered Pregnancy Rates (LDPR) Per Transfer or RetrievalGynecology & Reproductive Health · 2024
15. Pregnancy Rates in Frozen-Thawed Embryos Derived from Donor Oocytes According To the Mid-Luteal Phase Endometrial Echo PatternGynecology & Reproductive Health · 2024
16. Most Chronic Medical Conditions in Women are related to Increased Cellular Permeability and most can be Effectively Treated with Dopaminergic DrugsJournal of Biomedical Research & Environmental Sciences · 2024
17. Marked Improvement of Severe Treatment Resistant Migraine Headaches with the Dopaminergic Drug CabergolineJournal of Medical - Clinical Research & Reviews · 2024
18. The Use of Dopaminergic Drugs for Treating Cutaneous Discoid Lupus Erythematosus: A Case StudyJournal of Medical - Clinical Research & Reviews · 2024
19. Dopaminergic Drugs for the Successful Treatment of Bullous Pemphigoid (BP)Journal of Medical - Clinical Research & Reviews · 2024
20. Abstract 3587: Evidence that membrane progesterone receptors (mPR) play a key role in cancer metastases in most cases of metastatic cancerCancer Research · 2024